Zacks Investment Research
29 Jun 2026, 11:46 UTC · 1h ago
CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
29 Jun 2026, 11:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
CVRx reported first quarter 2026 results with $14.8 million in revenue and a loss per share of 50 cents, both of which beat Zacks Consensus Estimates. — Beating consensus estimates on both top and bottom lines typically drives positive investor sentiment and short-term price appreciation.
+0.40CVRx is expected to post revenues of $15.64 million in its upcoming report, representing a 15.1% increase year-over-year. — Double-digit projected revenue growth suggests a positive trajectory for the company's growth profile.
+0.20Consensus EPS estimates for both CVRx and Steris (STE) have remained unchanged over the last 30 days. — The lack of positive estimate revisions often signals a lack of new catalysts to sustain a bullish price trend.
-0.10Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
Shares rallied 11.6% after the company's first quarter performance surpassed Zacks Consensus Estimates.
The stock closed 2.4% higher in the last trading session, though overall monthly return is slightly negative.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.

Zacks Investment Research
2h ago